Sort   by:  
 Page size 
UnknownEngineering a modular FAP-targeting ferritin-based drug nanocarrier for enhanced glioblastoma theranostics.
Not available
S-EPMC12905753 | biostudies-literature
UnknownIntegrin α2β1-targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy.
Not available
S-EPMC8201891 | biostudies-literature
UnknownAblation of Discoidin Domain Receptor 1 Provokes an Osteopenic Phenotype by Regulating Osteoblast/Osteocyte Autophagy and Apoptosis.
Not available
S-EPMC9496360 | biostudies-literature
UnknownDynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan.
Not available
S-EPMC11540343 | biostudies-literature
UnknownImpact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.
Not available
S-EPMC13399790 | biostudies-literature
UnknownSurveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis.
Not available
S-EPMC11557369 | biostudies-literature
UnknownArtificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
Not available
S-EPMC9827079 | biostudies-literature
UnknownA people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co-V2 pandemic.
Not available
S-EPMC10148244 | biostudies-literature
UnknownRegorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Not available
S-EPMC8704159 | biostudies-literature
UnknownAir pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B.
Not available
S-EPMC12718713 | biostudies-literature
Sort   by:  
 Page size